These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 33946323)

  • 21. Extended-release carbamazepine for acute bipolar mania: a review.
    Owen RT
    Drugs Today (Barc); 2006 May; 42(5):283-9. PubMed ID: 16801991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rethinking the treatment paradigm for bipolar depression: the importance of long-term management.
    Baldassano CF; Ballas CA; O'Reardon JP
    CNS Spectr; 2004 Sep; 9(9 Suppl 9):11-8. PubMed ID: 15361807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxcarbazepine in the treatment of bipolar disorder: a review.
    Pratoomsri W; Yatham LN; Bond DJ; Lam RW; Sohn CH
    Can J Psychiatry; 2006 Jul; 51(8):540-5. PubMed ID: 16933591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome in the pharmacologic treatment of bipolar disorder.
    Keck PE; McElroy SL
    J Clin Psychopharmacol; 1996 Apr; 16(2 Suppl 1):15S-23S. PubMed ID: 8707996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials.
    Ceron-Litvoc D; Soares BG; Geddes J; Litvoc J; de Lima MS
    Hum Psychopharmacol; 2009 Jan; 24(1):19-28. PubMed ID: 19053079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Historical review of carbamazepine for the treatment of bipolar disorder.
    Stoner SC; Nelson LA; Lea JW; Marken PA; Sommi RW; Dahmen MM
    Pharmacotherapy; 2007 Jan; 27(1):68-88. PubMed ID: 17192163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bipolar disorders.
    McIntyre RS; Berk M; Brietzke E; Goldstein BI; López-Jaramillo C; Kessing LV; Malhi GS; Nierenberg AA; Rosenblat JD; Majeed A; Vieta E; Vinberg M; Young AH; Mansur RB
    Lancet; 2020 Dec; 396(10265):1841-1856. PubMed ID: 33278937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE; McElroy SL
    J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxcarbazepine in the treatment of bipolar and schizoaffective disorders.
    Popova E; Leighton C; Bernabarre A; Bernardo M; Vieta E
    Expert Rev Neurother; 2007 Jun; 7(6):617-26. PubMed ID: 17563245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
    Vasudev K; Goswami U; Kohli K
    Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamotrigine: a review of its use in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    Drugs; 2003; 63(19):2029-50. PubMed ID: 12962521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug treatments for bipolar disorder: 1--Acute manic or depressive episodes.
    Drug Ther Bull; 2005 Apr; 43(4):28-32. PubMed ID: 15849974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
    Smith LA; Cornelius V; Warnock A; Bell A; Young AH
    Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study.
    Peselow ED; Clevenger S; IsHak WW
    Int Clin Psychopharmacol; 2016 Jul; 31(4):218-23. PubMed ID: 26523730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes.
    Chen CH; Lin SK
    BMC Psychiatry; 2012 May; 12():47. PubMed ID: 22620289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
    Muzina DJ; Calabrese JR
    Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.